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2 Abstract 20 17β-estradiol (E2) modulates gene expression in the hypothalamic arcuate nucleus (ARC) to 21 control homeostatic functions. In the ARC, estrogen receptor (ER)  is highly expressed and is 22 an important contributor to E2's actions, controlling gene expression through estrogen response 23 element (ERE)-dependent and -independent mechanisms. The objective of this study was to 24 determine if known E2-regulated genes are regulated through these mechanisms. The selected 25 genes have been shown to regulate homeostasis and have been separated into three 26 subsections: channels, receptors, and neuropeptides. To determine if ERE-dependent or ERE-27 independent mechanisms regulate gene expression, two transgenic mouse models, an ERα 28 knock-out (ERKO) and an ERα knock-in/knock-out (KIKO), which lacks a functional ERE binding 29 domain, were used in addition to their wild-type littermates. Females of all genotypes were 30 ovariectomized and injected with oil or estradiol benzoate (E2B). Our results suggest that E2B 31 regulates multiple genes through these mechanisms. Of note, Cacna1g and Kcnmb1 channel 32 expression was increased by E2B in WT females only, suggesting an ERE-dependent 33 regulation. Furthermore, the NKB receptor, Tac3r, was suppressed by E2B in WT and KIKO 34 females but not ERKO females, suggesting that ER-dependent, ERE-independent signaling is 35 necessary for Tac3r regulation. The adrenergic receptor Adra1b was suppressed by E2B in all 36 genotypes indicating that ER is not the primary receptor for E2B's actions. The neuropeptide 37
Tac2 was suppressed by E2B through ERE-dependent mechanisms. These results indicate that 38 E2B activates both ER-dependent and independent signaling in the ARC through ERE-39 dependent and ERE-independent mechanisms to control gene expression. 40
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63
 Gene regulation by E2B occurs through ERE-dependent and ERE-independent 64 mechanisms.
65
 Gene expression varies greatly in oil-treated females between the genotypes. 66  Channels, receptors, and neurotransmitters are regulated in the ARC. 67
Introduction 68
The steroid hormone 17β-estradiol (E2) is known to regulate gene expression 69 throughout the brain. E2 primarily uses two classical nuclear receptors, estrogen receptor α 70 (ERα, Esr1,) and ERβ (Esr2) to regulate gene expression [1] . In the classical ER-mediated 71 mechanism, ligand binding to the receptor initiates receptor recognition of the estrogen 72 response element (ERE) to regulate gene transcription. In addition to classical regulation of 73 gene expression, E2 also functions through ERE-independent mechanisms. As reviewed in 74
McDevitt et al. (2008) , these mechanisms include ligand-independent ER signaling, rapid effects 75 through a membrane-associated ER, and ERE-independent signaling through protein-protein 76 interactions (AP-1, etc.) [2] . 77
In the hypothalamus, E2 mediates numerous homeostatic functions including 78 reproduction, energy homeostasis, core body temperature, fluid balance, motivational 79 behaviors, and stress physiology by regulating central neural pathways. Many of these 80 pathways originate in or pass through the arcuate nucleus (ARC) of the hypothalamus [1, [3] [4] [5] . 81
In the ARC, ERα is highly expressed and is the primary receptor used by E2 to control many 82 homeostatic functions [5, 6] . Few studies have examined the physiological effects of ER-83 mediated, ERE-dependent, and ERE-independent signaling on hypothalamic (ARC) gene 84 expression. 85 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 6 E2 also regulates ARC KNDy (Kisspeptin-Neurokinin B-Dynorphin) neuronal gene 117 expression [32] . Kisspeptin is involved in mediating negative and positive feedback of E2 on the 118 hypothalamic-pituitary-gonadal (HPG) axis and potentially has a role in energy homeostasis and 119 core body temperature [33] . Previous studies indicated that the Kiss1 gene is regulated by E2 120 through ERE-independent mechanisms in the mediobasal hypothalamus while dynorphin 121 expression is ERE-dependent [34] . Thus, we used these genes as positive and negative 122 controls for ERE-dependent and ERE-independent gene expression. Nothing is known about 123 the mechanisms behind the regulation of Neurokinin B (NKB, Tac2) or the KNDy receptors 124 (Kiss1r, Tac3r) by E2 in the ARC. Therefore, the objective of this study was to determine if 125 homeostatic genes involved in reproduction and energy homeostasis that have been identified 126 to be E2-responsive in the hypothalamus are regulated by E2 in the ARC through ERE-127 dependent or ERE-independent mechanisms using ovx WT, KIKO, and ERKO females. 128
129

Experimental 130
Animal care 131
All animal procedures were in compliance with institutional guidelines based on National 132
Institutes of Health standards and were performed with Institutional Animal Care and Use 133
Committee approval at Rutgers University. Adult C57BL/6 mice were housed under constant 134 photoperiod conditions (12/12 h light/dark cycle) and maintained at a controlled temperature 135 (25°C). Animals were given low phytoestrogen chow diet (<75 isoflavone ppm, Lab Diet 136 Advanced Protocol 5V75, St. Louis, MO, USA) and water ad libitum. Animals were weaned on 137 postnatal day 21 (PD21). Genotype was determined by using PCR products of extracted DNA 138 from ear clippings, using previously published protocols [9] . We used three genotypes of mice: 139 WT, KIKO, and ERKO (provided by Dr. Ken Korach, NIEHS) [9] . Crossing heterozygous WT/KI 140 males expressing the nonclassical ER knock-in with WT/KO heterozygous females generated 141 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Adult females (7-22 weeks and > 14 g body weight) were bilaterally ovx under isoflurane 153 anesthesia 7 days prior to sacrifice using sterile no-touch techniques according to the NIH 154 "Guidelines for Survival Rodent Surgery." Animals were given a dose of analgesic [4 mg/kg 155 carprofen (Rimadyl ® )] one day following surgery for pain management. Animals typically lost 1-156 2 g of weight one day after surgery. Females were monitored daily and allowed to recover for 5 157 days prior to the first injection of E2B or oil. The active metabolite of E2B is 17-estradiol. 158
Females were injected in the morning at 1000 h on post-ovx days 5 and 6 and sacrificed on 159 post-ovx day 7 in the morning at 1000 h. 160
161
Experimental design 162
Females of each genotype (WT, KIKO, ERKO) were ovx and separated into a control 163 sesame oil-treated group (n=6-9 per genotype) and an E2B-treated group (n=6-9 per genotype). 164 An E2B injection protocol was used that has been shown to alter gene expression in the 165 hypothalamus [19] . Animals were injected subcutaneously at 1000 h on post-ovx day 5 with 166 either 0.25 µg of E2B or sesame oil. On post-ovx day 6, a 1.5 µg dose of E2B or sesame oil was was run on the remaining wells. The same calibrator sample was run on each plate. Taqman   ®   220 primers were ordered for all genes, and KIKO and ERKO samples were analyzed. Positive and 221 negative tissue control samples and master mix (nuclease-free water) controls were added to 222 each run. In KIKO and ERKO qPCR plates, an additional sample (termed "pool") was analyzed 223 that included all the control oil samples from each respective genotype, to account for inter-plate 224 variation (data from C q values analyzed across plates). qPCR was performed on a 225
StepOnePlus™ Real-Time PCR System (Life Technologies, Inc.) using Taqman ® Gene 226 Expression Master Mix. For qPCR, we used 4 µg of cDNA (equivalent to 2 ng of total RNA). The 227 amplification protocol for all genes was as follows: a holding stage consisted of 2 min at 50 °C 228 and 95 °C for 10 min, followed by a cycling stage of 95 °C for 15 sec (denaturing) and at 60 °C 229 (annealing) for 1 min for 40 cycles. 230
In addition to the genes analyzed in the TLDA, we also analyzed the mRNA expression 231 of four additional genes: Adra1b, Cart, Ghsr and Chrm1, which were found to be E2-regulated in 232 our preliminary investigations or from the literature [37, 38] . Primers for these genes were 233 designed to span exon-exon junctions and were synthesized by Life Technologies, Inc., using 234
Clone Manager 5 software (Sci Ed Software, Cary, NC, USA). See Table 2 for a listing of 235 synthesized primers used for qPCR. For qPCR of these four genes, we used 4 µg of cDNA 236 (equivalent to 2 ng of total RNA) amplified with either PowerSYBR ® Green Master Mix (Adra1b, 237
Chrm1; Life Technologies, Inc.) or SsoAdvanced™ SYBR Green (Cart, Ghsr; BioRad, Inc., 238
Hercules, CA, USA) on CFX-Connect Real-time PCR Instrument (BioRad, Inc.). A standard 239 curve was generated for each primer pair using serial dilutions of BH cDNA in triplicate. 240
Efficiencies were calculated as a percent efficiency, listed in Table 2 . Amplification protocol for 241 Table 2 genes was as follows: initial denaturing 95 °C for 10 min (PowerSYBR ® ) or 3 min 242 (SsoAdvanced™) followed by 40 cycles of amplification at 94 °C for 10 sec (denaturing), 60 °C 243 for 45 sec (annealing), and completed with a dissociation step for melting point analysis with 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 cycles of 95 °C for 10 sec, 65 °C to 95 °C (in increments of 0.5 °C) for 5 sec and 95 °C for 245 5 sec. The reference genes used were β-actin (PowerSYBR ® ) and Gapdh (SsoAdvanced™). 246
Positive, negative, and water blank controls were included in the qPCR plate design. 247
Analysis of qPCR was done using the comparative C q method using a 1:20 diluted BH 248 cDNA (equivalent to 2 ng of RNA) sample from a male as the calibrator [39, 40] . All values were 249 normalized to oil controls and are expressed as relative mRNA expression. In all plates, we 250 maintained a consistent threshold level, set at the lowest but steepest slope of the exponential 251 curve. We calculated the linear quantity of target genes using the formula 2 -∆∆Cq . Data are 252 expressed as n-fold difference from the calibrator, normalized to oil controls. The n-fold 253 difference was used for statistical analysis. 254
255
Statistical analyses 256
qPCR data from the TLDA in WT females were initially analyzed using Data Assist ® 257 software (Life Technologies, Inc.) to determine significant differences between oil-and E2B-258 treated samples using a t-test with a false discovery rate (Benjamini-Hochberg method) set to a 259 p < 0.05. All further statistical analyses were performed using GraphPad ® Prism software 260 (GraphPad Software, Inc., La Jolla, CA, USA). Data were expressed as mean ± SEM and 261
analyzed by a two-way ANOVA (genotype x treatment), followed by a post-hoc Bonferroni's 262 multiple comparison test between oil-and E2B-treated groups within each genotype (WT, KIKO, 263 ERKO). Uterine weights were analyzed using a two-way ANOVA (genotype x treatment) 264 followed by Bonferroni's multiple comparison test between oil-and E2B-treated groups, within 265 each genotype (WT, KIKO, ERKO). Plasma E2 levels of all three genotypes were pooled 266 together for oil vs. E2B treatment analysis, as there was no genotype effect (data not shown), 267 and analyzed using a Student's t-test. In all experiments, a p < 0.05 was considered to be 268 significant. To determine relative gene expression among genotypes, we compared oil-treated 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 12 WT, KIKO, and ERKO females. These data were analyzed using a one-way ANOVA followed by 270 a post-hoc Bonferroni's multiple comparison test. 271 272
Results
273
Uterine weights and plasma E2 levels 274
Following sacrifice, we dissected out the uterus of each female to confirm the 275 hypertrophic actions of E2, an ERα-mediated process [41] . Past studies in our lab have 276 suggested that E2B (250 ng/dose) replacement every other day for 4 weeks significantly 277 increased the uterine weight in WT females [12] . E2B significantly increased the uterine weight 278 in WT females (Table 3 ; ANOVA: F(2,24) = 34.75, p < 0.0001), but did not increase uterine 279 weight in KIKO and ERKO females. There was no significant difference in body weight at 280 sacrifice for E2B-treated females in all genotypes. The age of sacrifice of females was as 281 follows: WT: 12-23 weeks (average: 18.2 ± 1.0 weeks); KIKO: 7-23 weeks (average: 17.2 ± 1.6 282 weeks); ERKO: 7-23 weeks (average: 13.9 ± 1.8 weeks). There were no age-specific effects 283 when we analyzed the 2 ∆∆Cq -values for all regulated genes across genotypes (data not shown). 284
We pooled plasma E2 data across genotypes (WT, KIKO, ERKO) because there was no 285 genotype effect observed (data not shown). Plasma E2 concentrations were as follows: oil-286 treated: 5.2 ± 0.4 pg/ml; E2B-treated: 28.82 ± 7.0 pg/ml. There was a significant increase in 287 plasma E2 levels 24 h post-injection between oil-and E2B-treated groups (p < 0.001). 288 289 E2B dose regulates ARC gene expression 290 E2B-treatment in ovx WT females significantly regulated the mRNA expression of 14 291 genes in the ARC (Table 4) . These genes include those that function as cation channels, 292 receptors for hormones and neurotransmitters, and neuropeptides. E2 replacement significantly 293 suppressed the mRNA expression of Adra1b, Cart, Chrm1, Esr1, Kiss1, Pdyn, NKB (Tac2), and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 Tac3r and significantly augmented expression of Cacna1g, Esr2, Ghsr, Kcnmb1, Kiss1r, and 295
Pgr. The remaining genes in Table 4 were not regulated by E2B in WT females. 296
After studying WT ARC mRNA expression, we then analyzed all the genes in ARC 297 tissue from KIKO and ERKO females injected with either sesame oil or E2B using individual 298 Taqman ® assays or custom primers. In comparing the genotypes, we found that the mRNA 299 expression of two cation channels, which are involved in neuronal excitability, were upregulated 300 by E2B in WT females only: Cav3.1 (Cacna1g), a subunit of the T-type Ca 2+ channels, (Figure 301 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 E2B also regulated several important neuropeptide genes in the ARC. In WT females 319 only, prodynorphin (Pdyn) and neurokinin B (Tac2) expression were suppressed by E2B twofold 320 Interestingly, Cart expression was suppressed by E2B in WT and KIKO females, but was 324 increased by E2B in ERKO females ( Figure 3D ; ANOVA: F(2,42) = 7.719, p < 0.01). 325 Surprisingly, we did not find a significant change in other E2-regulated arcuate genes including 326 POMC and TH, which may be due to differences in treatment paradigms or rodent models [1, 327 42, 43] . 328
329
ARC genes are differentially expressed in KIKO and ERKO ovx oil-treated females 330
Differences in gene expression across these genotypes may provide insight into 331 signaling and feedback mechanisms involved in ERE-dependent, ERE-independent and ERα-332 independent signaling in the ARC. To determine if mRNA expression of the selected genes was 333 different between the genotypes, we calculated the relative mRNA expression for each gene by 334 normalizing the KIKO and ERKO oil groups to the WT oil group. Data were analyzed using a 335 one-way ANOVA followed by post-hoc Bonferroni's multiple comparison tests between WT vs. 336 KIKO, WT vs. ERKO, and KIKO vs. ERKO females. See Table 5 for results. 337
The mRNA levels of multiple genes were lower in KIKO and ERKO oil-treated females 338 as compared to WT females. Interestingly, Cart expression was lower in KIKO females but not 339 ERKO females compared to WT females. Cart expression in KIKO females was lower than in 340 ERKO females (ANOVA: F(2, 14) = 19.43, p < 0.0001). For eight genes, mRNA expression in 341 KIKO and ERKO females was lower compared to WT females, with no difference observed 342 between KIKO and ERKO females. These genes include: Abcc8 (the regulatory subunit for K ATP 343 channels; ANOVA: F(2,14) = 15.63, p < 0.001), Chrm1 (ANOVA: F(2,14) = 5.657, p < 0.05), 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17 ERE-dependent and ERE-independent mechanisms to regulate gene expression in the 396
hypothalamus. This present study compared gene expression in WT, KIKO, and ERKO mouse 397 models to characterize mechanisms of E2 regulation of ARC gene expression. We determined 398 that regulation of ARC gene expression by E2B, with E2 being the active hormone, occurs 399 through both ERE-dependent and ERE-independent mechanisms. The genes regulated by 400 ER-mediated, ERE-dependent and ERE-independent mechanisms in this study include cation 401 channels, receptors, and neuropeptides associated with reproduction, energy balance, stress, 402 and other homeostatic functions. However, it is necessary to note that our ERE-independent 403 KIKO mouse model is nonselective to other hormone response element (HRE) motifs and may 404 bind to other HREs to regulate transcription [47] . The development of an "EAAE" ERα mouse 405 that lacks ERE-and HRE-dependent signaling would be useful in future studies to distinguish 406 between those two types of signaling [47] . 407
In the current study, E2 (or treatment with E2B) increased channel expression of 408
Cacna1g and Kcnmb1 in WT females only, a finding supported by previous studies, but not 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 18 E2 has been found to regulate mRNA expression of a range of potassium channels in 420 the guinea pig [16] . In the current study, we found that expression of Kcnmb1, a calcium- Chrm1 expression in the ARC. In the present study, E2B suppressed Chrm1 expression in the 438 ARC through ERE-dependent signaling. Past studies in the rat hippocampus also suggest that 439
Chrm1 is decreased in response to immediate E2 replacement following ovx [50] . The current 440 study used a different E2 replacement paradigm, yet it would be informative to examine Chrm1 441 expression at different time points after E2B administration in the ARC to determine the time-442 dependent regulation of Chrm1 expression. We also found suppressed Chrm1 expression in 443 KIKO and ERKO females compared to WT. This difference may result in a decrease in 444 muscarinic signaling in the ARC of KIKO and ERKO females, which can be examined in future1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 19 experiments using electrophysiology to assess muscarinic activity in ARC neurons. The growth hormone secretagogue receptor, GHSR, is a GPCR involved in ghrelin 467 signaling. E2B treatment has been shown to increase Ghsr expression in the ARC in mice [30] . 468 We determined that the increase in ARC Ghsr expression by E2, which is regulated by ERE-469 dependent mechanisms, as E2B-treatment did not affect Ghsr expression in KIKO or ERKO 470 females. Ghrelin signaling in the hypothalamus illuminates the relationship of E2 on feeding 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 . This is supported by our study, which 485 suggests that the E2-mediated Esr1 suppression occurs through ERE-dependent mechanisms. 486
There are no previous studies that identify the mechanism for this E2-mediated Esr1 decrease. 487
Furthermore, E2B treatment augmented the expression of ER (Esr2) in WT and KIKO females. 488
These data indicate that, unlike with ER, ER is regulated in the ARC by ERE-independent, 489 ER-mediated signaling. GPER/GPR30, a membrane estrogen receptor, was not regulated by 490 E2 in any genotype. ER (Esr1) expression was lower in ERKO compared to WT and KIKO 491 females. GPER (Gpr30) expression was lower in ERKO compared to WT females. Lastly, there 492 was no difference in expression of ER (Esr2) between all genotypes. 493
In addition, E2B treatment increased expression of Pgr in WT females only. These 494 results are consistent with multiple studies that suggest E2B increases Pgr in the hypothalamus, 495 priming the brain for progesterone's reproductive and behavioral actions [64, 65] , but also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   21 suggest that Pgr is regulated through ERE-dependent, ER-mediated signaling pathway. Pgr 497 expression is two-to threefold higher in both KIKO and ERKO females compared to WT 498 females. Interestingly, the relative expression of Pgr in oil-treated KIKO and ERKO females is 499 equal to the relative levels of Pgr in E2B-treated, WT females. Higher expression of Pgr in the 500 ARC may play a role in the lack of normal estrous cycles in KIKO and ERKO females. 501
In the present study, E2B treatment regulated multiple neuropeptides that are 502 coexpressed in KNDy neurons of the ARC and their receptors. Kisspeptin-expressing neurons 503 are expressed in two main regions in the rodent hypothalamus [32] . The first region is the 504 anteroventral periventricular (AVPV) nucleus, which is referred to as the surge center for its role 505 in the LH surge in female rodents [32] . The second region is the ARC, which contains kisspeptin 506 neurons that coexpress Kisspeptin (Kiss1), Neurokinin B (Tac2) and Dynorphin (Dyn, Pdyn) 507
[66]. These KNDy neurons are known for their contribution to negative feedback of E2 on the 508 HPG axis and are hypothesized to be the pulse generator for the secretion of GnRH into the 509 median eminence [67, 68] . Additional studies suggest that kisspeptin neurons directly contact 510
GnRH neurons in the median eminence to control GnRH excitability and pulsatility [68] . Since 511 then, KNDy neurons have also been shown to integrate feeding signals through input from 512 peptides such as ghrelin, leptin, and insulin [69, 70] . Our results corroborate previous data 513 demonstrating that Kiss1 regulation by E2 is nonclassically mediated [34] . Kiss1 expression also 514 was lower in both KIKO and ERKO females than WT females. Because ARC Kiss1 is involved 515 in negative feedback, perhaps the lower expression indicates that negative feedback is 516 disrupted in these genotypes, in part, due to lower expression of Kiss1 [67, 68] .. 517
Amongst the other two KNDy neuropeptides, Neurokinin B (Tac2) expression is 518 suppressed by E2 in WT females only. Our data suggest that Tac2 expression is primarily 519 controlled by ERE-dependent signaling much like Pdyn [29, 41] . As with Kiss1, Tac2 expression 520 is lower in both KIKO and ERKO females. The suppressed expression of Tac2 in these 521 genotypes also supports the hypothesis that lower expression of both Kiss1 and Tac2 play a1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 22 role in the disruption of negative feedback in these genotypes. Because Neurokinin B (NKB, 523
Tac2) is involved in GnRH pulse generation, the lower expression in KIKO and ERKO 524 contributes to the dysregulation of the GnRH actions on the gonadotropes in these genotypes 525 [67, 68] . Since Kiss1 is the only KNDy gene that is regulated by ER ERE-independent 526 mechanisms, the KNDy pulse generator (NKB, Dyn) for GnRH secretion is primarily controlled 527 by ERE-dependent mechanisms. Finally, Pdyn expression, the other KNDy neuropeptide, is 528 suppressed by E2B through ERE-dependent transcription. These data support previous studies 529 and was used in this study as a "negative" control for ERE-independent signaling [34] . 530 Interestingly, Pdyn expression was higher in KIKO females compared to WT females unlike 531
Kiss1 and Tac2 expression. Elevated Pdyn may further disrupt the pulse generator in this 532 genotype as this neuropeptide is considered a negative regulator of the pulse generator [67, 533 68] . 534
KNDy-associated receptors are also regulated by E2. Tac3r, the NKB receptor, is 535 suppressed in WT and KIKO females by E2B treatment, suggesting that, like Kiss1, Tac3r 536 suppression is through an ERα-mediated, ERE-independent pathway [71] . These results 537 suggest that both ERE-dependent and ERE-independent mechanisms are involved in the 538 control of KNDy neuropeptides and their receptors and are necessary to maintain a functional 539 HPG axis. In fact, current evidence suggests that mutations in Tac3r lead to problems in 540 reproductive development including hypogonadotrophic hypogonadism, similar to mutations in 541
Kiss1r [72, 73] . The decrease in Tac3r and Tac2 associated with E2B treatment may both be 542 involved in KNDy-mediated control of negative feedback and the GnRH pulse generator. 543 Kiss1r, the receptor for Kiss1, is increased by E2B treatment in all three genotypes. This 544 upregulation suggests that E2 regulation of Kiss1r expression is ERα-independent and 545 potentially mediated by ER, GPER, or perhaps the putative STX-responsive, Gq-coupled mER 546
(Gq-mER) [1, 16, 74] . Alternatively, the increase in Kiss1r expression may be due, in part, to a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 23 decrease in the desensitization of the receptor, as Kiss1 peptide and gene expression is highly 548 reduced by E2 in the ARC [25, 32, 75] . Future studies should examine E2 regulation of Kiss1r 549 peptide expression selectively in the median eminence, where KNDy neurons contact GnRH 550 neurons expressing the kisspeptin receptor [19, 66] . Kiss1r expression was higher in ERKO 551 females compared to their WT and KIKO females, which correlated with a decrease in the 552 ligand expression in the ERKO. However, the effect of E2 across the genotypes was similar, 553
suggesting that the E2-mediated increase is robust and not dependent on relative baseline 554 expression levels. 555
Lastly, Cart gene expression, which produces a neuropeptide involved in reward, stress, 556 and feeding behavior [76, 77] , is differentially regulated by E2 in the three genotypes. CART 557 activity has been shown to suppress feeding much like E2 in rodents and primates [76, 77] . There are a number of additional receptors that can be involved in ERα-independent, E2 568 signaling and may be involved in the control of Kiss1r, Adra1b, and Cart. In addition to ERα, the 569 classical receptor ERβ can also regulate E2-responsive genes through ERE-dependent and 570 ERE-independent signaling. Although ERα is more highly expressed in the ARC compared to 571
ERβ, studies suggest that ERβ signaling is still present [27] and may function as a 572 compensatory mechanism for gene regulation by E2 in the ERKO since Esr2 is expressed in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 24 ARC during development [79] . In addition, non-nuclear ER-mediated E2 signaling can also 574 regulate gene expression through G-protein coupled membrane estrogen receptors (GPER) and 575 the putative Gq-mER [80] . Evidence suggests that GPER is activated by E2 and is important for 576 rapid cell signaling and homeostatic functions, although is it not regulated by E2 in the ARC [81, 577 82]. Gq-mER activates PLC-PKC signal transduction pathway and functions in energy 578 homeostasis, bone remodeling, and core body temperature including activation of hypothalamic 579 neurons [7] as well as control of ARC gene expression [1] . 580
We found that there were a number of genes that were not regulated by E2B but did 581
show differences in expression amongst genotypes. These genes include Abcc8, Bcl2, 582
Sirt1, and Th. The range of expression differences amongst the genotypes differs for each 584 gene. While there is no easily discernable pattern of expression differences, these changes may 585 result in deleterious effects of ER loss (knockout) on reproductive and energy homeostasis. 586
Furthermore, it is important to note that the present study only examined differences in gene 587 expression among oil-treated genotypes, which may not produce functional differences in ARC 588 neurons or in the protein of these enzymes, signaling molecules, receptors, and cation 589 channels. Future experiments will be needed to confirm these potential effects and if these 590 differences are due to a developmental role of ER signaling, both ERE-dependent and ERE-591 independent, in ARC gene expression. Nonetheless, comparison of gene expression across 592 genotypes is an important tool for enhancing our understanding of ER's role in ARC gene 593 expression and homeostatic functions. 594
While past studies have examined regulation of gene expression by E2 in the ARC, few 595 studies to date have used the ER KIKO transgenic mouse model as a tool to identify molecular 596 mechanisms of E2 regulation. The results of our study indicate that genes involved in 597 hypothalamic functions such as reproduction, energy homeostasis, and neuronal excitability are 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 25 regulated by E2 through multiple ERα-mediated and ER-independent pathways as has been 599 previously suggested [1] . It is important to note that gene expression in our study is a 600 measurement of the steady-state mRNA expression. Unfortunately, due to the small size of the 601 ARC nucleus in mice, it is not possible to conduct immunoblotting of protein expression within a 602 single animal. Because mRNA and protein levels seldom correlate when comparing gene 603 expression and immunohistochemistry [25] , future studies will examine the expression and 604 activity of many of these genes, especially the cation channels and GPCRs, using 605 electrophysiology. These experiments would further characterize the role of ER-mediated, 606 ERE-dependent and -independent signaling on ARC gene expression and neuronal functions. 607
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